141 related articles for article (PubMed ID: 15223651)
1. Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.
Zhang H; Li Y; Li H; Bassi R; Jimenez X; Witte L; Bohlen P; Hicklin D; Zhu Z
Leuk Lymphoma; 2004 Sep; 45(9):1887-97. PubMed ID: 15223651
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
4. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways.
Santos SC; Dias S
Blood; 2004 May; 103(10):3883-9. PubMed ID: 14726393
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway.
Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250
[TBL] [Abstract][Full Text] [Related]
6. Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.
Wang ES; Teruya-Feldstein J; Wu Y; Zhu Z; Hicklin DJ; Moore MA
Blood; 2004 Nov; 104(9):2893-902. PubMed ID: 15238424
[TBL] [Abstract][Full Text] [Related]
7. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
Lu D; Shen J; Vil MD; Zhang H; Jimenez X; Bohlen P; Witte L; Zhu Z
J Biol Chem; 2003 Oct; 278(44):43496-507. PubMed ID: 12917408
[TBL] [Abstract][Full Text] [Related]
8. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling.
Saito A; Sugawara A; Uruno A; Kudo M; Kagechika H; Sato Y; Owada Y; Kondo H; Sato M; Kurabayashi M; Imaizumi M; Tsuchiya S; Ito S
Endocrinology; 2007 Mar; 148(3):1412-23. PubMed ID: 17170094
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy.
Dias S; Choy M; Alitalo K; Rafii S
Blood; 2002 Mar; 99(6):2179-84. PubMed ID: 11877295
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
12. Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line.
Coppola S; Narciso L; Feccia T; Bonci D; Calabrò L; Morsilli O; Gabbianelli M; De Maria R; Testa U; Peschle C
Cell Death Differ; 2006 Jan; 13(1):61-74. PubMed ID: 15962006
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.
Revoltella RP; Menicagli M; Campani D
Cytokine; 2012 Mar; 57(3):347-59. PubMed ID: 22200506
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
16. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
Dias S; Hattori K; Zhu Z; Heissig B; Choy M; Lane W; Wu Y; Chadburn A; Hyjek E; Gill M; Hicklin DJ; Witte L; Moore MA; Rafii S
J Clin Invest; 2000 Aug; 106(4):511-21. PubMed ID: 10953026
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
Masood R; Kundra A; Zhu S; Xia G; Scalia P; Smith DL; Gill PS
Int J Cancer; 2003 May; 104(5):603-10. PubMed ID: 12594815
[TBL] [Abstract][Full Text] [Related]
18. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
19. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.
Liang Y; Hyder SM
Endocrinology; 2005 Aug; 146(8):3632-41. PubMed ID: 15845615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
